Skip to content

A study about clinical effect of target-directed fluid therapy in CLCVP partial hepatectomy

The clinical effect of target-directed fluid therapy in the control of partial hepatectomy with low central venous pressure

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030311
Enrollment
Unknown
Registered
2020-02-28
Start date
2020-02-22
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of anesthesia on partial hepatectomy

Interventions

control group:Routine experience fluid replacement

Sponsors

Southern District of the First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-II; 2. Aged 18 to 65 years, undergoing elective partial liver resection patients with hepatic segment and above; 3. No significant abnormalities in heart and lung function before operation; 4. Liver function Child-Pugh grade A or B; 5. Diabetes or high Good blood pressure control.

Exclusion criteria

Exclusion criteria: 1. Anemia, abnormal blood coagulation; 2. Coronary atherosclerosis; 3. Cerebrovascular accidents, 4. Allergies to narcotics, 5. Long-term sedation, 6. History of mental illness, 7. Non-sinus during operation, arrhythmia, duration greater than 5 minutes, 8. Surgery Assessing patients who are unsuitable for liver resection and controlled low central venous pressure failure, major intraoperative bleeding, and admitted to ICU after operation.

Design outcomes

Primary

MeasureTime frame
Hemodynamic index;Blood gas index;Type and amount of infusion;

Secondary

MeasureTime frame
Liver and kidney function after surgery;Use of vasoactive drugs;Quality of anesthesia;Postoperative complications;

Countries

China

Contacts

Public ContactWang Yong

South area of the First Affiliated Hospital of University of science and technology of China

13966687794@139.com+86 13966687794

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026